1 March 2008 Optical clearing of flowing blood using dextrans with spectral domain optical coherence tomography
Author Affiliations +
J. of Biomedical Optics, 13(2), 021107 (2008). doi:10.1117/1.2909673
Abstract
Spectral domain optical coherence tomography (SDOCT) images have been used to investigate the mechanism of optical clearing in flowing blood using dextrans. The depth reflectivity profiles from SDOCT indicate that dextrans become increasingly more effective in reducing scattering in flowing blood, except for 5 mgdl-1 of D×500, with increasing molecular weights (MW 70,000 and 500,000) and concentrations (0.6, 2, and 5 mgdl-1). Among the tested dextrans, Dx500 at 2 mgdl-1 had the most significant effect on light scattering reduction with the strongest capability to induce erythrocyte aggregation. D×500 at 5 mgdl-1 contributes more refractive index matching but induces a decrease in aggregation that leads to the same level as 0.6 mgdl-1 D×500. Previous studies identified various mechanisms of light scattering reduction in stationary blood induced by optical clearing agents. Our results suggest that erythrocyte aggregation is a more important mechanism for optical clearing in flowing blood using dextrans, providing a rational design basis for effective flowing blood optical clearing, which is essential for improving OCT imaging capability through flowing blood.
Xiangqun Xu, Lingfeng Yu, Zhongping Chen, "Optical clearing of flowing blood using dextrans with spectral domain optical coherence tomography," Journal of Biomedical Optics 13(2), 021107 (1 March 2008). https://doi.org/10.1117/1.2909673
JOURNAL ARTICLE
6 PAGES


SHARE
RELATED CONTENT

Blood immersion and sedimentation study using OCT technique
Proceedings of SPIE (October 25 2001)
Study of optical clearing of blood by immersion method
Proceedings of SPIE (February 17 2011)
Sedimentation of immersed blood studied by OCT
Proceedings of SPIE (May 04 2001)
Optical clearing of blood by dextrans
Proceedings of SPIE (September 22 2003)

Back to Top